CIBC Innovation Banking, a North American financial partner for investors and entrepreneurs, allocated an additional $1.5 billion of growth capital to support later-stage startups as the venture capital market slows.
The new initiative aims to back later-stage, venture-backed companies across software, life sciences, healthcare and cleantech industries, with deals ranging from $50-$100 million in capital.
Providing its portfolio companies with cross-border networks and financial support, CIBC Innovation Banking works closely with the companies it lends to, as the team supports a company’s growth through every step of the IPO journey.
CIBC Innovation Banking delivers strategic advice, cash management and funding to innovation companies across North America, the UK, and select European countries at each stage of their business cycle, from startup to IPO and beyond. With offices in Atlanta, Austin, Boston, Chicago, Denver, London, Menlo Park, Montreal, New York, Reston, Seattle, Toronto and Vancouver, the team has extensive experience and a collaborative approach that extends across CIBC’s commercial banking and capital markets businesses.
FinSMEs
04/07/2022